Dennis A. Carson

FZD7 expression marks mammary tumor-initiating cells.

Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model

Generation and Application of a Reporter Cell Line for the Quantitative Screen of Extracellular Vesicle Release

Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infection.

A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity

Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody

Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model

The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity

Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells

Transcriptome Sequencing Reveals Potential Mechanism of Cryptic 3’ Splice Site Selection in SF3B1-mutated Cancers

Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands as Influenza Virus Vaccine Adjuvants Induce Rapid, Sustained, and Broadly Protective Responses

Pre-clinical Specificity and Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1

Systematic transcriptome analysis reveals tumor-specific isoforms for ovarian cancer diagnosis and therapy

Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy

The WNT receptor FZD7 is required for maintenance of the pluripotent state in human embryonic stem cells

TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant

Identification of Substituted Pyrimido[5,4-<i>b</i>]indoles as Selective Toll-Like Receptor 4 Ligands